Merck’s Challenge on Shingles Vaccine Sparks Debate Over Mass Torts Case Management
Trenton, New Jersey – The pharmaceutical company Merck is set to appeal a court decision regarding its shingles vaccine, which has sparked controversy over its mass torts case management tool. The appeal will test the implications of a controversial legal precedent that could have far-reaching consequences for future complex litigations. The case revolves around a claim by a group of plaintiffs who allege that Merck’s vaccine caused them to develop severe complications, including nerve damage and chronic pain. The plaintiffs argue that Merck should be held liable for the alleged injuries, as they believe the … Read more